Even if you aren’t a big investor, chances are you’re still aware that the marijuana industry has been the hottest thing since the internet on the stock market. For the last two or three years, investors have gained (and lost) a lot betting on these stocks, with Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) emerging as one of the top players in this young…
Read More
Aurora Cannabis (TSX:ACB)(NYSE:ACB) is a global medical cannabis company founded in 2006. The company maintains nine popular medical cannabis brands, including Aurora, CanniMed, and MedReleaf. Exclusive foreign government supply contracts with Italy, Germany, Brazil, and Australia give Aurora a definite advantage over competitors. Aurora’s stock price has not done as well as peers such as Canopy Growth (TSX:WEED)(NYSE:CGC) and Cronos…
Read More
Back in mid-April, I’d warned investors about the cannabis sector, as we awaited the next round of earnings from several of the top producers. As expected, earnings were a mixed bag for producers like Canopy Growth (TSX:WEED)(NYSE:CGC) and Aurora Cannabis (TSX:ACB)(NYSE:ACB). Overall, recreational sales have slipped in 2019. This is jarring after the hype surrounding recreational legalization. Horizons Marijuana Life…
Read More
Bruce Linton is a household name in the cannabis industry. He became the poster boy for the industry’s growth and all the potential that it offered. He’d often be in interviews on TV discussing the goals for Canopy Growth (TSX:WEED)(NYSE:CGC) and did a great job of captivating audiences and getting people excited about the company. However, when he was let…
Read More
After some very impressive moves from stocks in the sector — including Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) shares increasing 3,662% since 2014 — many marijuana investors are sitting on some sizeable gains. Most are prepared to hold on for the long-term, convinced we’ve only scratched the surface of marijuana’s potential. Remember, the drug has only been legal in Canada for less…
Read More
CannTrust Holdings’s (TSX:TRST)(NYSE:CTST) recent downfall has been well documented. The company was caught illegally growing marijuana in areas not approved by Health Canada. The fallout was immediate. In the days following the bombshell, CannTrust lost 60% of its value. Although it has since recouped some of that, the company is still trading at a near 50% discount to where it…
Read More
HEXO (TSX:HEXO)(NYSE:HEXO) has given back most of its 2019 gains, and investors are wondering if the Canadian marijuana producer is a buy right now or should be avoided. Let’s take a look at the current situation to see if HEXO deserves to be in your portfolio. Market conditions Every new industry goes through volatility, and the rapid rise of the…
Read More
The second half of this decade has seen the emergence of two explosive asset classes that have been big draws for millennials. Bitcoin launched in January 2009 and remained something of a novelty for libertarian-minded and anti-establishment investors until a 2017 bull run changed everything. Cannabis is a different story. Its use dates to ancient times, but its entrance into…
Read More
Cronos Group (TSX:CRON)(NASDAQ:CRON) is perhaps the most expensive cannabis stock as far as forward valuations are concerned. It’s also been the target of several analyst downgrades thanks to its premium multiple to its peers. With the entire sector experiencing a pullback during the past few weeks, here are two reasons why you should buy Cronos, and one reason why you…
Read More
The departure of the embattled Bruce Linton from Canopy Growth (TSX:WEED)(NYSE:CGC) on July 3 seems to be hurting the largest cannabis company in the world. The company’s founder was mainly responsible for Canopy’s growth for the past six years. Today, there’s doubt as to whether investors should still buy WEED. Linton left the company with 5.6 million square feet of…
Read More